As senior director of strategic initiatives, Luke Thorstenson works with INBT leadership to manage critical priorities related to research operations, interdisciplinary collaborations, and the development of core research centers. He shapes and executes short- and long-term strategies to important INBT initiatives, ensures seamless communication and coordination across Hopkins and external stakeholders, and represents INBT leadership in critical engagements.

Thorstenson has over 12 years of experience in the biotechnology sector, including roles in corporate development, strategic planning, and market intelligence. Prior to joining Hopkins, he held leadership roles at Alliance for Regenerative Medicine, Adjuvant Partners, and Hitachi Chemical Advanced Therapeutics Solutions, and Orgenesis. At Orgenesis, Inc., he served as vice president of corporate development and strategy, where he led corporate development, strategic planning, and partnerships in the cell and gene therapy space. He also co-led fundraising efforts that resulted in significant growth for the company. Thorstenson received his MBA with a focus on healthcare management from Johns Hopkins University and a bachelor of arts in philosophy from the University of Texas at Austin